Dr. Weiner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7703 Floyd Curl Dr
San Antonio, TX 78229Phone+1 210-257-1400Fax+1 210-257-1428
Education & Training
- University of North Carolina HospitalsResidency, Internal Medicine, 1970 - 1974
- New York University School of MedicineClass of 1970
Certifications & Licensure
- TX State Medical License 1976 - 2024
- NC State Medical License 1973 - 1978
- American Board of Internal Medicine Internal Medicine
Clinical Trials
- TBTC Study 23A: Pharmacokinetics of Intermittent Isoniazid and Rifabutin in HIV-TB Start of enrollment: 1999 Jul 01
- TBTC Study 23C: Pharmacokinetics of Intermittent Rifabutin and Isoniazid With Daily Efavirenz Start of enrollment: 1999 Nov 01
- TBTC Study 26 PK: Rifapentine Pharmacokinetics in Children During Treatment of Latent TB Infection Start of enrollment: 2005 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- Pharmacokinetic-Pharmacodynamic Evidence From a Phase 3 Trial to Support Flat-Dosing of Rifampicin for Tuberculosis.Huy X Ngo, Ava Y Xu, Gustavo E Velásquez, Nan Zhang, Vincent K Chang
Clinical Infectious Diseases. 2024-06-14 - 3 citationsLongitudinal Model-Based Biomarker Analysis of Exposure-Response Relationships in Adults with Pulmonary Tuberculosis.Andrew D Gewitz, Belén P. Solans, William R. Mac Kenzie, Chad Heilig, William C. Whitworth
Antimicrobial Agents and Chemotherapy. 2021-07-12 - 203 citationsFour-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis.Susan E. Dorman, Payam Nahid, Ekaterina V. Kurbatova, Patrick P. J. Phillips, Kia E Bryant
The New England Journal of Medicine. 2021-05-06
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: